Abbott Labs (ABT) Debt by Year
Abbott Labs carried $9.9B in long-term debt against $8.5B in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 21.6% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Abbott Labs has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ABT Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $9.9B-21.6% | $12.6B-7.2% | $13.6B-6.4% | $14.5B-16.0% | $17.3B-6.6% | $18.5B+11.2% | $16.7B-13.9% | $19.4B-28.9% | $27.2B+31.6% | $20.7B+252.3% | $5.9B+73.0% | $3.4B+0.1% | $3.4B-81.3% | $18.1B+50.2% | $12.0B |
| Cash & Equivalents | $8.5B+11.9% | $7.6B+10.4% | $6.9B-30.2% | $9.9B+0.8% | $9.8B+43.3% | $6.8B+77.2% | $3.9B+0.4% | $3.8B-59.1% | $9.4B-49.5% | $18.6B+272.3% | $5.0B+23.1% | $4.1B+16.9% | $3.5B-67.8% | $10.8B+58.5% | $6.8B |
ABT Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $29.6B+132.7% | $9.9B-21.6% | $11.6B-9.6% | $12.9B-1.6% | $12.7B+1.3% | $12.6B-7.2% | $12.8B-11.4% | $13.1B-9.8% | $12.6B-14.0% | $13.6B-6.4% | $14.5B-5.4% | $14.6B-13.1% |
| Cash & Equivalents | $6.8B+4.1% | $8.5B+11.9% | $7.5B-0.6% | $7.0B-0.5% | $6.5B+3.9% | $7.6B+10.4% | $7.6B+12.7% | $7.0B-10.8% | $6.3B-31.4% | $6.9B-30.2% | $6.7B-30.1% | $7.8B-12.3% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Abbott Labs financials
Frequently Asked Questions
What was Abbott Labs's long-term debt in fiscal year 2025?
Abbott Labs carried $9.9B in long-term debt against $8.5B in cash and equivalents at the end of fiscal year 2025.
How fast is Abbott Labs's long-term debt growing?
Abbott Labs (ABT) long-term debt fell by 21.6% year over year, from $12.6B to $9.9B in fiscal year 2025.
How has Abbott Labs's long-term debt changed over the years?
Across the 15 fiscal years this page covers, Abbott Labs (ABT) long-term debt went from $12.0B in fiscal year 2011 to $9.9B in fiscal year 2025.
What was Abbott Labs's long-term debt in the most recent quarter?
Abbott Labs (ABT) reported $29.6B in long-term debt in Q1 2026. This represents an increase of 132.7% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Abbott Labs (ABT) reported on that line in every period on record.